梅花生物：2025年半年度归属于上市公司股东的净利润同比增长19.96%

Core Viewpoint - The company reported a decline in revenue for the first half of 2025, while net profit showed significant growth compared to the previous year [2] Financial Performance - The company achieved operating revenue of 12,280,450,603.53 yuan for the first half of 2025, representing a year-on-year decrease of 2.87% [2] - The net profit attributable to shareholders of the listed company was 1,767,950,116.89 yuan, reflecting a year-on-year increase of 19.96% [2]